Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
PURPOSE: Previously human glandular kallikrein 2 (hK2) has been implicated to predict pathologically organ confined prostate cancer (PCa) in patients with stage T2 disease. Now we evaluated the usefulness of hK2, as measured by 2 entirely different immunoassay designs, to enhance the discrimination...
المؤلفون الرئيسيون: | Haese, A, Vaisanen, V, Lilja, H, Kattan, M, Rittenhouse, H, Pettersson, K, Chan, D, Huland, H, Sokoll, L, Partin, A |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2005
|
مواد مشابهة
-
Standardization of two immunoassays for human glandular kallikrein 2.
حسب: Haese, A, وآخرون
منشور في: (2003) -
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
حسب: Haese, A, وآخرون
منشور في: (2003) -
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
حسب: Steuber, T, وآخرون
منشور في: (2005) -
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
حسب: Haese, A, وآخرون
منشور في: (2000) -
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
حسب: Haese, A, وآخرون
منشور في: (2001)